Last €5.25 EUR
Change Today +0.153 / 3.00%
Volume 65.7K
APS On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 1:54 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - ariad pharmaceuticals inc (APS)

Name (Connections)Board RelationshipsTitleKey Developments
Massimo Radaelli Ph.D. 21 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit CommitteeAriad Pharmaceuticals Inc. announced delayed 10-Q filing
08/17/99
Wayne Wilson 33 RelationshipsIndependent Director, Chairman of Audit Committee, Member of Executive Committee and Member of Nominating & Corporate Governance Committee 
Jay LaMarche 9 RelationshipsFinancial Advisor, Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 
Robert Whelan Jr. 28 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee 

Compensation Committee* - ariad pharmaceuticals inc (APS)

Name (Connections)Board RelationshipsTitle
Athanase Lavidas Ph.D. 16 RelationshipsLead Director, Chairman of Nominating & Corporate Governance Committee, Member of Executive Committee and Member of Compensation Committee
Massimo Radaelli Ph.D. 21 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee
Norbert Riedel Ph.D. 186 RelationshipsDirector and Member of Compensation Committee
Robert Whelan Jr. 28 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee
APS Compensation vs. Industry
695.8K
361.6K
Chief Executive Officer
436.5K
258.8K
Chief Financial Officer
Share price activity for ARIAD PHARMACEUTICALS INC (APS)
52 Week Price Performance
APS
Industry Average

Nominating Committee* - ariad pharmaceuticals inc (APS)

Name (Connections)Board RelationshipsTitleKey Developments
Athanase Lavidas Ph.D. 16 RelationshipsLead Director, Chairman of Nominating & Corporate Governance Committee, Member of Executive Committee and Member of Compensation CommitteeARIAD Announces Appointment of Hugh Cole as Chief Business Officer
04/2/14
Massimo Radaelli Ph.D. 21 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit CommitteeAriad Pharmaceuticals, Inc. Appoints Alexander J. Denner, Ph.D. to a Two-Year Term on the company's Board of Directors
02/21/14
Wayne Wilson 33 RelationshipsIndependent Director, Chairman of Audit Committee, Member of Executive Committee and Member of Nominating & Corporate Governance CommitteeARIAD Pharmaceuticals Inc. Appoints Sarah J. Schlesinger to the Board of Directors
07/17/13
Jay LaMarche 9 RelationshipsFinancial Advisor, Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeAriad Pharmaceuticals Inc. Announces Executive Changes
02/21/13

Corporate Governance Committee* - ariad pharmaceuticals inc (APS)

Name (Connections)Board RelationshipsTitle
Jay LaMarche 9 RelationshipsLead Director, Chairman of Nominating & Corporate Governance Committee, Member of Executive Committee and Member of Compensation Committee
Athanase Lavidas Ph.D. 16 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee
Massimo Radaelli Ph.D. 21 RelationshipsDirector and Member of Compensation Committee
Wayne Wilson 33 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee
APS and Competitor
Insiders vs. External
Board
20%
80%
Ariad Pharmaceuticals Inc.
22%
78%
Arena Pharmaceuticals, Inc.
9%
91%
Array BioPharma, Inc.
14%
86%
Cell Therapeutics, Inc.
14%
86%
Exelixis, Inc.
29%
71%
INSYS Therapeutics, Inc.
Insiders
External Board Members

Executive Committee* - ariad pharmaceuticals inc (APS)

Name (Connections)Board RelationshipsTitle
Harvey Berger M.D. 9 RelationshipsPrincipal Founder, Chairman of the Board, Chief Executive Officer, President and Chairman of Executive Committee
Jay LaMarche 9 RelationshipsFinancial Advisor, Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Athanase Lavidas Ph.D. 16 RelationshipsLead Director, Chairman of Nominating & Corporate Governance Committee, Member of Executive Committee and Member of Compensation Committee
Wayne Wilson 33 RelationshipsIndependent Director, Chairman of Audit Committee, Member of Executive Committee and Member of Nominating & Corporate Governance Committee
Elizabeth Wyatt 22 RelationshipsFormer Director, Member of Audit Committee and Member of the Executive Committee
Management Effectiveness Relative to the Industry
Return on Equity
NM
Return on Assets
NM
Return on Total Capital
NM
TEV/Total Revenue(LTM)
NM

Advisory Committee* - ariad pharmaceuticals inc (APS)

Name (Board Relationships)/Title Board Affiliations
Morris Loeb 9 Relationships
Chairman of Medical Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APS:GR €5.25 EUR +0.153

APS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $6.18 USD -0.12
Array BioPharma Inc $3.79 USD -0.05
Cell Therapeutics Inc $3.07 USD +0.08
Exelixis Inc $3.29 USD -0.03
Insys Therapeutics Inc $38.64 USD +1.88
View Industry Companies
 

Industry Analysis

APS

Industry Average

Valuation APS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 29.3x
Price/Book 7.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 24.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.